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The current chemotherapy for drug susceptible Tuberculosis (TB) does not rapidly eradicate the entire 
Mycobacterium tuberculosis population. It is not clear how a small fraction of bacteria (antibiotic 
survivors) can evade prolonged exposure to anti-TB drugs. The mechanisms which are responsible for 
this phenotype are unknown mainly because isolating this rare subpopulation of bacteria is extremely 
difficult. We hypothesised that fluorescent activated cell sorting (FACS) can be used to identify and 
isolate this subpopulation. In our approach, we first sought to identify fluorescent dyes which would 
distinguish viable from non-viable bacteria after antibiotic treatment. M. tuberculosis was grown to log 
phase and exposed to antibiotic treatment for 72 or 168 hours. At different time points cells from the 
treated cultures were stained individually and in combination with dyes for membrane integrity, 
membrane potential, reactive oxygen species, and esterase activity.  We observed drug specific staining 
patterns with marked heterogeneity for most of the stains and antibiotics tested. Our results also indicate 
that staining with fluorescent dyes can provide information about the potential mode of action of new 
antimycobacterial drugs. When we evaluated CellROX Deep red as a marker for viability we observed 
that the CellROX Deep red negative cells were enriched for viable bacteria after 24 hours of treatment 
with clofazimine. CellROX Deep red, is a dye which detects reactive oxidative species in cells.  Further 










Mycobacterium tuberculosis is the pathogen which causes the global health problem Tuberculosis (TB). 
Despite the availability of intense drug treatment, TB resulted in the deaths of 1.5 million people among 
the estimated 9.6 million incident cases of TB in 2014  (WHO, 2015). South Africa is among the six 
countries that had the largest number of annual incident TB cases globally (WHO, 2015). TB is 
normally diagnosed using sputum smear microscopy and culture or a rapid genetic diagnostic  test such 
as GeneXpert (Helb et al., 2010) before anti-TB chemotherapy is started. 
 
The current treatment regimen for drug susceptible TB involves 2 months’ intensive phase of orally 
administered isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA) and ethambutol (EMB) followed 
by 4 months’ continuation phase of INH and RIF. These antibiotics are also referred to as the first-line 
drugs for TB management. Anti-mycobacterial drugs vary in their mode of action targeting different 
cellular processes (Table 1). This long treatment regimen results in poor patient adherence which may 
lead to the emergence of drug-resistant TB (WHO, 2015). The need for such lengthy treatment is not 
clear but may include poor tissue penetration of antibiotics (Dartois and Barry, 2010), suboptimal 
pharmacokinetics (Boeree et al., 2015) as well as the presence of a rare subpopulation of M. tuberculosis 
which is drug tolerant (Chengalroyen et al., 2016). Recent studies to shorten TB therapy were not 
successful and resulted in relapse after completion of therapy (Gillespie et al., 2014). Efforts to shorten 
TB therapy will require a better understanding of how M. tuberculosis can survive such prolonged 
exposure to antibiotics (Zhang et al., 2012;Honeyborne et al., 2016). 
 
1.2. Drug-resistant TB 
 
The emergence of drug-resistant TB poses a major threat to the public health sector’s aim to control TB 
(WHO, 2015). Multi-drug resistant (MDR) TB is when M. tuberculosis is resistant to INH and RIF. 
Extensively drug resistant (XDR) TB is defined as M. tuberculosis that is resistant to INH and RIF as 
well as a quinolone and one of the injectable second-line agents (CDC, 2006). Drug resistance is a result 
of genetic mutations in M. tuberculosis which results in reduced permeability of the membrane to the 
antibiotic, production of enzymes that degrade the antibiotic, modification of the antibiotic activation 
pathways or modification of the drug target (Zhang et al., 1993;Caugant et al., 1995;Cohen et al., 2014). 
Drug-resistant TB is treated by combining the first-line drugs to which the strain is still susceptible and 
second-line drugs. Treatment for drug resistant TB can last between 18- 24 months (Mitchison and 




Table 1.1. Summary of mechanism of action of some of the anti-mycobacterial drugs used in TB treatment. 
Drug Mechanism of action Cellular process targeted 
First-line drugs 
Isoniazid (INH) INH is activated by a catalase-peroxidase 
enzyme to forms an adduct with NAD that 
inhibits InhA an enzyme required for fatty 
acid elongation and mycolic acid synthesis 
(Knox et al., 1952;Heym et al., 1993). 
Cell wall synthesis  
Rifampicin (RIF) RIF binds to rpoB gene product (RNA 
polymerase) and prevents elongation of 
RNA (Miller et al., 1994).  
Transcription  
Pyrazinamide (PZA) PZA is converted to pyrazinoic acid but its 
mechanism of action is not clear, although 
interaction with the ribosome is one 
possibility (Zhang and Mitchison, 2003) 
Translation and probably other processes 
Ethambutol (EMB) EMB binds arabinosyl transferases 
interrupting arabinan synthesis. Arabinan is 
a component of arabinogalactan the major 
polysaccharide of the mycobacterial cell 
wall (Mikusová et al., 1995;Takayama and 
Kilburn, 1989). 






Fluoroquinolones inhibit DNA supercoiling 
by binding to DNA gyrase (Drlica, 1999). 
DNA replication and transcription 
Clofazimine (CFZ) CFZ binds to NADH dehydrogenase 
resulting in production of reactive oxidative 






STR, KAN and AMK bind to the 16S 
ribosomal RNA on the 30s ribosomal 
subunit inhibiting the initiation of translation 
(Chan et al., 2003) (Nair et al., 1993). 
Protein synthesis 






1.3. Persisters in TB 
 
In contrast to drug resistance, antibiotic tolerance is a non-heritable mechanism by which bacteria can 
survive antibiotics. This phenotype was first described with penicillin treatment (Hobby et al., 1942) 
(Bigger, 1944). Despite prolonged exposure to antibiotics a small proportion of bacteria survived. 
Critically when these survivors were re-grown in the absence of drug and then re-challenged with 
antibiotics their minimum inhibitory concentration (MIC) was not elevated and the same kill kinetics 
were observed. This type of experiment has been reproduced in many bacteria and critically shows that 
antibiotic tolerance is not due to the hereditable acquisition of drug resistance conferring mutations 
(Balaban et al., 2004;Wayne and Hayes, 1996;Keren et al., 2004). The antibiotic survivors selected 
were originally called persisters, and this term has stuck. Balaban et al. (2004) described Type I 
persisters as a preexisting population of non-growing cells generated during the stationary phase of 
growth and Type II persisters as a subpopulation of slowly growing cells that are continuously being 
generated in all stages of the growth. Unfortunately, in the study of TB, the term persister has also been 
used to describe M. tuberculosis during clinical latency. However, for the purposes of this thesis 
persister will be used to describe antibiotic tolerant bacteria that have been selected by antibiotics. 
     
Persisters are the rare subpopulation of bacteria which survive the antibiotic treatment that kills their 
genetically identical siblings (Mc Dermott, 1958). Thus persisters are phenotypic variants of the drug 
susceptible bacteria (Zhang et al., 2012;Lewis, 2010). Unlike resistant bacteria, persisters do not 
proliferate in the presence of an antibiotic (Figure 1). When the antibiotic is removed, persisters give 
rise to a genetically identical population which exhibits the same kill curve as the original population 
(Keren et al., 2004). Importantly the decline in bacterial load in the sputum from TB patients initiating 
therapy is biphasic similar to that seen in killing by antibiotics of bacteria grown in liquid media. It has 
been proposed that  this is due to the presence of a heterogeneous population of bacteria and the 
selection of persisters that take greater antibiotic exposure to kill (Jindani et al., 2003). Transcriptional 
profiling of the response of M. tuberculosis to drug treatment has been used to define the mechanism 
of action of antibiotics and it has also been used to understand drug tolerant populations in sputum  
(Honeyborne et al., 2016;Tudó et al., 2010;Wakamoto et al., 2013).   In this study, we also use the term 











Figure 1.1. Killing kinetics during treatment with a bactericidal antibiotic. The panels to the right show: 1. 
The initial population of bacteria being exposed to a bactericidal antibiotic contains normally growing cells 
(green) and persisters (red) 2. Killing of the normally growing cells (green) on exposure to antibiotics but not the 
persisters (red). 3. Persistent cells (red) are killed with very slow kinetics and are therefore still present after 
antibiotic exposure. The arrow flanking the panels on the right shows that if persister cells are regrown without 
antibiotic they give rise to a population which is similar to the original population. In the graph the bold line shows 
the timing of killing after exposure to a bactericidal antibiotic. Initially there is rapid killing (1) until persister cells 
become enriched (2) and finally slow killing of the selected persisters (3).  The black dashed line shows the growth 
of a drug resistant mutant strain in the presence of an antibiotic. The green line shows the kill kinetics of a drug 
susceptible population. The red line shows that persister cells are a preexisting population in the bacterial 
population. CFU/mL – Colony forming units /mL (Lewis, 2010;Maisonneuve and Gerdes, 2014). 
 
Single gene mutation in vitro and in vivo studies have identified several pathways which may be 
involved in persister formation in M. tuberculosis. The pathways which have been implicated include 
energy related pathways, the stringent response regulator, cell wall synthesis, transporter systems and 
protein degradation pathways (Zhang et al., 2012). Some of the identified genes include sucB a subunit 
of the pyruvate dehydrogenase complex involved in the TCA cycle (Bryk et al., 2008), cydC involved 
in cytochrome bd assembly (Dhar and McKinney, 2010), pcaA and tgs 1 which code for proteins 
involved in cell wall synthesis (Glickman et al., 2000;Deb et al., 2009) and toxin-antitoxin (TA) 





1.3.1. Challenges in eradicating persisters in TB 
 
Bigger (1944) initially proposed intermittent drug dosing as a strategy of eliminating persisters 
assuming that this would allow persisters to become susceptible again once the antibiotic was removed 
(Zhang et al., 2012). This strategy worked in vitro under defined conditions however in vivo the 
complex environment and pharmacokinetics of different antibiotics would present a potential risk of 
the emergence of drug resistance (Cogan, 2006;Zhang et al., 2012). The inclusion of pyrazinamide 
(PZA) in TB treatment contributed greatly to the reduction of chemotherapy duration to  6 months (Fox, 
1981). PZA is thought to primarily target persisters and is less effective against actively growing 
bacteria and is therefore referred to as a drug with sterilizing activity (Zhang and Mitchison, 2003). 
Rifampicin is also a critical drug in short course chemotherapy and is considered to have sterilizing 
activity. There are many in vitro assays that have been used to try and replicate the persister state in 
humans including starvation, hypoxia, and other models of slowly dividing bacteria. Other drugs have 
been found to have activity in these models including bedaquiline and fluoroquinolones and are 
considered therefore to have activity against persisters (Zhang, 2005;Dhar and McKinney, 2010;Singh 
et al., 2010). However, the inclusion of fluoroquinolones in chemotherapy regimens didn’t shorten 
therapy duration below 6 months so it is still unclear how in vitro models relate to drug activity against 
persisters in humans (Ji et al., 1998;Zhao et al., 1999;Chan et al., 2004).  
 
While the use of drug screens to identify agents that target persisters is important, it is also very 
important to identify the mechanisms that lead to persister formation in mycobacteria (Zhang et al., 
2012). This could lead to a more rational approach to eliminate persisters if we understood better the 
key metabolic pathways required to maintain viability in the face of antibiotics.  Depending on the 
conditions and the drug, persisters usually represent less than 1% of a population of actively growing 
cells. The major barrier to the discovery of mechanisms responsible for persister formation is the lack 
of methods for isolating persister cells (Lewis, 2007) from cells that are dead or dying. 
 
1.3.2. Single cell approaches in studying persisters 
 
Single cell analysis is an approach that can provide insight into the heterogeneity of bacterial cells 
within a bacterial population. This heterogeneity may arise as an adaptive trait to counteract 
environmental disturbances (Manina et al., 2015;Trouillon et al., 2012).  Microfluidic technologies and 
real time imaging have been used separately or in combination to show heterogeneity in microbial 
populations (Rusconi et al., 2014;Lin et al., 2014;Balaban et al., 2004). Wakamoto et al. (2013), used 
microfluidics to show the production of heterogeneous responses from a population of genetically 
identical mycobacteria after exposure to antibiotics. Fluorescent reporter tags have been used in 




activity in replicating and dormant cells (Jain et al., 2016;Golchin et al.). Although these microscopy 
based approaches have the advantage of being able to track the fate of single cells after antibiotic 
treatment, they are essentially low-throughput. Most experiments that have been conducted to date 
report on hundreds of cells. But if the frequency of true persisters is less than 1%, the current format of 
single cell analysis may not be sufficiently sensitive to track rare subpopulations. An alternative 
technique which has emerged for higher throughput bacterial single cell analysis is flow cytometry 
(Ambriz-Aviña et al., 2014;Rehse et al., 1995;Czechowska et al., 2008). Since its introduction in the 
mid-1900s flow cytometry has gained popularity in the identification and characterization of 
microorganisms at single cell level (Shapiro, 2015;Vives-Rego et al., 2000). This is mainly because 
flow cytometry offers extremely high-throughput (millions of cells can be rapidly analyzed) quantitative 
and qualitative multi-parameter analysis (Wu et al., 2016).  
 
1.4. Flow cytometry 
 
Flow cytometry is a process for measuring the physical and chemical properties of cells in a fluid stream 
(Shapiro, 2003). This technique is a fast and effective way for single cell analysis making it suitable for 
assays involving numerous cells. The fluidics system of a flow cytometer causes hydrodynamic 
focusing of particles (cells) on a laser beam which interrogates one cell at a time. The cell can be 
subjected to one or multiple laser beams at the interrogation point (Tracy et al., 2010). The signals from 
the cell are detected by photomultiplier tubes and converted into quantitative electronic signals. 
Sophisticated software exists to interpret these signals (Virgo and Gibbs, 2012). Flow cytometry data 
can be displayed on a logarithmic or linear scale in the form of histograms, contour plots, density plots 
or dot plots. Dot plots have been most popular in graphical display compared to other forms (Maher 
and Fletcher, 2005).  
 
Light scattering properties of cells are measured to give the side scatter (SSC) signal which shows the 
granularity of the cells and forward scatter (FSC) signal which represents the size of the cell (Shapiro, 
2003). The relationship between light scatter and cell morphology can be complicated by the many 
factors such as the scatter angle geometry of the cytometer. Therefore, it should be noted that the FSC 
signal does not always produce a linear correlation with cell size (Müller and Nebe-von-Caron, 
2010;Becker CL et al., 2002). In spite of these factors, measuring scatter properties has been used to 
show that there was a change in the FSC signal due to impaired cell division after antibiotic treatment 
(Wickens et al., 2000). SSC has also been used as measure the accumulation of metabolites an indirect 
measure of the metabolic state of cells (Fouchet et al., 1993). In addition to identifying subpopulations 
with similar properties, flow cytometers can be used to locate and separate rare events from 





Some flow cytometers use electrical or mechanical means to isolate and collect cells with desired 
characteristics and this is referred to as cell sorting (Shapiro, 2003).  The combination of measuring 
fluorescent signals and cell sorting resulted in the formation of the core concept of modern flow 
cytometry referred to as  fluorescence activated cell sorting (FACS) (Tracy et al., 2010).  The most 
common type of single cell sorting is droplet sorting which is based on the assigning of a charge to a 
droplet containing the particle of interest (Figure 2). The droplet is charged via the stream-charging 
wire attached to the flow cell.  As the charged droplet passes through the charged deflection plates, 
electrostatic attraction and repulsion cause the charged droplet to be deflected to the left or right 
depending on its polarity (BDFACSAriaTM). This process allows for direct sorting into appropriate 
liquid media or onto solid agar (Müller and Nebe-von-Caron, 2010). The sorted cells can be used for 
further assays for example transcriptomics or viability. Tzur et al. (2011), has shown that combining 
the measurement of multiple parameters produced better results when sorting when compared to just 

















Figure 1.2. The principles of Fluorescence activated cell sorting (FACS). A sample containing cells is injected 
into the sheath fluid where the cells are funnelled to a single line of cells. The cells pass through the laser beam 
where signals of the light scattering and fluorescent properties of the cells are sent to detectors. At this point the 
nozzle generates droplets containing one cell per drop. When a particle which meets the sorting criteria is 
identified, an electrical charge is applied to the droplet containing the particle. When the charged droplet gets to 
the deflection plates (electromagnets), the polarity of the droplet causes the path of the droplet to be deviated so 
that the droplet is collected in the appropriate sample tube. Uncharged droplets are collected in the waste vial (not 





Physical parameters, sometimes called intrinsic factors, are measured without dyes. Structural and 
functional information on cells also called extrinsic factors can be measured using fluorescent stains or 
reporters (Shapiro, 2003). Fluorescent indicators are an established tool for distinguishing phenotypes 
at single cell level however very few fluorescent stains have been used to study bacterial 
physiology(Joux and Lebaron, 2000) (Maglica et al., 2015). Flow cytometers with multicolour laser 
diodes have a wide variety of wavelengths which allow for the use of multiple fluorescent probes hence 
analysis of multiple parameters (Telford et al., 2015). Flow cytometry has been used to study many 
biological organisms including multicellular organisms e.g. Drosophila embryos, eukaryotic cells, 
bacteria and viruses (Shapiro, 2005;Virgo and Gibbs, 2012;Nebe-von-Caron et al., 2000;Strober, 2001). 
Flow cytometry with fluorescent stains has been used to measure DNA content, enzyme activity, cell 
membrane integrity, proliferative activity, oxidative stress, membrane polarity, total protein and many 
other factors (Shapiro, 2005). 
 
1.5. Microbiological applications of flow cytometry 
 
1.5.1. Cell count and cell proliferation measurements 
 
Enumeration of cells can be achieved reliably with statistical confidence using flow cytometry (Wang 
et al., 2010). Although changes in turbidity in opaque media are commonly used to estimate cell count, 
the presence of abiotic particles may overestimate the cell number (Müller and Nebe-von-Caron, 2010). 
Flow cytometry is more reliable than the classical method of determining cell number by counting of 
CFU. The major drawback of the CFU method is the exclusion of some cells which may not be able to 
grow under the experimental conditions (Barer, 1997). This has resulted in flow cytometry being widely 
used in the routine monitoring of drinking water and food safety  (Czechowska et al., 2008;Hammes 
and Egli, 2010). To improve the sensitivity of enumeration, nucleic acid stains such as 4´,6-diamidino-
2-phenylindole (DAPI) and SYBR® Green 1 can be incorporated to stain cells and this excludes 
interference signals from the instrument or sample cells (Hammes and Egli, 2010;Völsch et al., 1990). 
Bacterial growth can be evaluated by monitoring the DNA content of the cell (Cooper, 2006). The DNA 
distribution pattern represents the chromosome number in a cell and this can be used to show the cell 
cycle stage of the bacteria  (Cooper, 1969;Button and Robertson, 2001). DAPI and Hoechst dyes are 
cell membrane permeant which fluoresce blue upon binding to the minor groove of double stranded 
DNA (Arndt-Jovin and Jovin, 1989;Wolfe et al., 1987). These dyes which are excited using the UV 
laser are non-toxic to cells nevertheless they exhibit a higher affinity for binding to AT clusters in DNA 





1.5.2. Drug susceptibility testing and analysis of efflux pump activity using flow cytometry 
 
Norden et al. (1995) were the first to determine the susceptibility of M. tuberculosis to antibiotics agents 
within 24 hours. This is based on the ability of cellular esterase to hydrolyse fluorescein diacetate 
(FDA). FDA is a non-fluorescent molecule based on fluorescein. After cleavage of side chains by 
intracellular esterases FDA becomes fluorescent (Kirk et al., 1998;Moore et al., 1999;Veal et al., 2000). 
Recent attempts to improve drug susceptibility testing in sputum samples incorporated a bacteriophage 
with a fluorescent reporter (O'Donnell et al., 2015). Phage infection in the presence of drug could be 
detected by flow cytometry and predicted resistance. In addition to predicting susceptibility, flow 
cytometry coupled with fluorescent stains can be used to predict the mechanism of action of new 
antibiotics (Hendon-Dunn et al., 2016).   
Over expression of efflux pumps is one of the mechanisms responsible for the emergence of drug-
resistant bacteria (Piddock, 2006;Machado et al., 2012). Flow cytometry has been used to measure the 
rate of efflux pump expression by measuring the rate of efflux and accumulation of ethidium 
bromide(Paixão et al., 2009).   This may be an important technique to identify persisters as Szumowski 
et al. (2012), reported that drug tolerance in M. tuberculosis could be associated with the emergence of 
macrophage-induced mycobacterial efflux pumps and efflux pump inhibitors could potentially be used 
to shorten the chemotherapy for drug susceptible TB (Szumowski et al., 2012).  
1.5.3. Viability testing using flow cytometry 
 
The conventional method for measuring cell viability is plating a small volume of the culture and 
incubating at the appropriate conditions then counting the number of colonies (Postgate, 1969). This 
technique may be ideal for fast growing organisms like E. coli or M. smegmatis. However for slow 
growing microorganisms like M. tuberculosis, which take at least 21 days to form visible colonies, this 
technique is not ideal and has impaired drug screens and the clinical evaluation of new drugs (Davey et 
al., 2004). The CFU method  may also be limiting when there is a subpopulation which is viable but 
non-culturable under the plating conditions used (Amann et al., 1995). These and other disadvantages 
CFU enumeration have attracted the use of viability stains which provide a rapid method of determining 
viability and other physiological characteristics of the cell (Davey et al., 2004). The common viability 
stains are based on assessing membrane permeability, enzyme activity or membrane polarity. Thus, 
assessing the dynamics of the molecular events (Figure 2) that are necessary to sustain cell survival and 





Figure 1.3. Schematic illustration of fundamental cellular processes. Cellular processes essential for survival, 
include: DNA replication (1), transcription (2), translation (3), ATP synthesis (4), enzymatic reactions involved 
in metabolic processes (5), respiration (6), symport and antiport of various molecules (7) (Manina and McKinney, 
2013). It is not clear what role these processes play in the survival of persisters. 
1.5.4. Evaluating cell membrane integrity 
 
The ability of the cell to retain or exclude dyes from the cell has been used to discriminate live or dead 
bacteria. The exclusion of propidium iodide (PI), ethidium bromide and Sytox dyes from bacterial cells 
is used to assess membrane integrity (Bunthof et al., 2001;Shu et al., 2012).  PI and Ethidium bromide 
are hydrophilic cationic, DNA intercalating dyes that bind at a stoichiometry of 4-5 base pairs per 
molecule (Comas and Vives-Rego, 1998;Horobin et al., 2006;Waring, 1965). Both dyes are excluded 
from viable cells and fluoresce red when they bind to DNA. Sytox nucleic acid stains are cyanine based 
and cell impermeant dyes, as well binding non-selectively to DNA. These dyes are commonly used as 
dead cell stains and fluoresce either red, green, blue or orange making them favourable for multiple 
colour analysis (Hendon-Dunn et al., 2016;Hammes and Egli, 2010;Chan et al., 2012).   
Though PI and ethidium bromide are assumed to be excluded from viable cells they have been found 
to stain intact cells (Nebe-von-Caron et al., 2000). Determining membrane integrity by assessing the 
retention of dyes may be limiting due to variable uptake of the substrate, lack of enzymes for  dye 
activation and active efflux of the dye (Nebe-von-Caron et al., 2000). In order to interpret the staining 
results with these stains have been used in combination with nucleic acid binding dyes that are 





1.5.5. Enzyme activity as a measure of viability 
 
Measuring the ability of cells to hydrolyse substrates for dehydrogenases or esterases has been used to 
indicate metabolic activity (Nebe-von-Caron et al., 2000). These substrates are non-polar, permeable 
non-fluorescent molecules which become fluorescent and are retained within the cell upon hydrolysis. 
The redox dye 5-cyano-2,3-ditoyl tetrazolium chloride (CTC) has been used to detect respiring bacteria 
in aquatic environments. Dehydrogenases reduce CTC to a red fluorescent formazan product. 
Yamaguchi and Nasu (1997) reported that CTC is toxic to cells and some bacteria can not reduce the 
dye. These factors have limited its use in identifying bacteria (Joux and Lebaron, 2000).  
Fluorescein diacetate (FDA) and its derivatives are the commonly used fluorophores for measuring non-
specific esterase activity (Clarke et al., 2001;Sträuber and Müller, 2010). The hydrolysis of FDA 
produces a fluorescent product, fluorescein. However, some media components e.g. tryptone result in 
FDA hydrolysis in the absence of live cells and other culture media quench the signal of fluorescein 
(Clarke et al., 2001). These and other factors have reduced the use of FDA as a stain for evaluating 
esterase activity. Calcein acetoxymethyl esters are more widely used esterase substrates because 
calcein, the fluorescent product is brighter and has superior cell retention compared to fluorescein (Joux 
and Lebaron, 2000;Krämer et al., 2015). In addition, calcein acetoxymethyl esters come in variable 
colours which allows multiparameter staining to be done using a palate of either calcein blue, green, 
violet, red or orange (Probes, 2010;Roth et al., 1997;Krämer et al., 2015;Johnson, 2010).   
1.5.6. Measuring membrane polarity using flow cytometry  
 
The electrical potential of the membrane is an important property for the cell as it governs signal 
transduction, nutrient uptake, respiration and other processes (Epps et al., 1994). Fluorescent dyes have 
been used to measure membrane potential as an indicator of the physiologic state of cytoplasmic 
membrane and viability of the bacteria. Bacteria maintain a membrane potential > 100 mV across the 
membrane. Charged lipophilic dyes readily pass through the membrane (Shapiro and Nebe-von-Caron, 
2004). Bis -1,3-dibutylbarbituric acid trimethine oxonol DiBAC4 (3), is an anionic, lipophilic probe for 
measuring membrane potential. The dye is excluded by healthy polarized cells and upon entering  
depolarized cells it binds to lipid rich surfaces (Breeuwer and Abee, 2000).  
A cationic cyanine based dye 3,3´-diethyloxacarbocyanine iodide DiOC2 (3), is also used to measure 
the membrane potential of bacteria (Mason et al., 1995). Metabolically active bacteria maintain an 
electrically negative charge on the cytosolic surface of the cell membrane. The positively charged 
DiOC2 (3) aggregates on the cytosolic membrane causing the red fluorescence and the monomeric form 
of the dye gives rise to the green fluorescence (Novo et al., 1999). This dye has both green and red 
fluorescence, the former is dependent on cell size whereas the latter is dependent on both cell size and 




to green fluorescence is a more accurate way of measuring membrane potential using DiOC2(3) (Nebe-
von-Caron et al., 2000). Comparison of the staining with membrane potential uncouplers like carbonyl 
cyanide m-chlorophenyl hydrazine (CCCP) improves the reliability of the staining by providing a 
positive control (Joux and Lebaron, 2000). In addition to uncouplers membrane potential dyes can be 
used in conjunction with  nucleic acid binding dyes like SYTO 17 as a way of improving the 
reproducibility (Comas and Vives-Rego, 1997).  
1.5.7. Measuring oxidative stress using flow cytometry 
 
Cellular metabolism in aerobic organisms generates toxic radicals called reactive oxidative species 
(ROS). ROS species include superoxide anion (O2-), hydroxyl radical (·OH), peroxynitrite (ONOO-), 
hydrogen peroxide (H2O2) and nitric oxide (NO˙) (Korshunov and Imlay, 2006;Dwyer et al., 2009). 
ROS levels are controlled by the activity of enzymes like superoxide dismutase, catalase and other free 
radical quenching agents such as glutathione (Cabiscol et al., 2010). When cells experience oxidative 
stress, there is an imbalance between production of reactive oxygen species (ROS) and the ability of 
cells to scavenge them. This in turn causes oxidative damage to the membrane lipids, protein and nucleic 
acids and can lead to cell death (Belenky et al., 2015).  
Bactericidal antibiotics have been reported to produce ROS as part of their lethality in Escherichia coli 
and Staphylococcus aureus (Kohanski et al., 2007;Dwyer et al., 2014;Lobritz et al., 2015).  Although 
it is unclear to what extent this is the lethal mode of action of antibiotics or a by-product of the failure 
of other essential metabolic pathways (Keren et al., 2013). Either way the detection of ROS could be a 
method of identifying a terminal event in antibiotic treatment.  CellROX dyes, 4-amino-5-methylamino-
2´,7´-diflurorescein diacetate (DAF-FM) and dihydroethidium are some of the dyes that have been used 
to measure the oxidative status of cells (Lagman et al., 2015;Dwyer et al., 2014). Table 2 shows the 
characteristics of some widely used fluorescent stains for detecting oxidative stress.  
Table 1.2. Summary of the properties of some stains used to detect oxidative stress. 
Dye  Chemistry Ex/Em 
(λ) 
Species detected 
CellROX Green  Binds to DNA upon oxidation.  
 Signal localised to nucleus and mitochondria. 
 Can be used with fixed cells. 
508/525 HO· 
·O2- 
CellROX Orange  Localised to cytoplasm 




CellROX Deep Red  Localised to cytoplasm  





 Binds to DNA upon oxidation. 
 Localised to nucleus. 





Grant et al. (2012), reported that mycobacterial persisters can be eradicated by treating with antibiotics 
which generate ·OH and it has been suggested that INH and PZA induce ROS formation in the cell 
leading to autophagy (Goletti et al., 2013).  Piccaro et al. (2014), used electro paramagnetic resonance 
to show that there is production of ·OH after RIF interacts with its target the β- subunit of RNA 
polymerase and this could participate in the killing of M. tuberculosis. The activation of INH by KatG 
has been shown to result in the production of NO˙ which potentially results in its antimycobacterial 
activity (Timmins and Deretic, 2006). FACS is therefore a promising approach to evaluate if the 
presence of ROS after antibiotic treatment would be able to predict cell death in M. tuberculosis. 
1.5.8. The use of reporter systems in flow cytometry 
 
Fluorescent proteins (FP) are used in flow cytometry to measure some cell parameters directly or 
indirectly (Dhandayuthapani et al., 1995;Valdivia and Falkow, 1997). Enhanced mutants of the green 
fluorescent protein (GFP) from Aequorea victoria jellyfish, which is introduced into cells by cloning, 
has been used as a reporter for gene expression (Wu et al., 2016;Patterson and Lippincott-Schwartz, 
2002). Modification of GFP has led to a wide range of FPs with variable excitation and emission 
characteristics which have allowed investigators to combine FPs with fluorescent stains. Reporter 
systems have been used to measure gene expression, cell division and the metabolic status of cells 
(Southward and Surette, 2002;Vromman et al., 2014). Recently fluorescent dilution of induced GFP 
has been used to measure single cell growth and this has been successfully used in Salmonella and 
mycobacteria (Helaine et al., 2014;Mouton et al., 2016). Another type of reporter are fluorescent 
oligonucleotide hybridisation probes which have been used to detect bacterial nucleic acids to identify 
species in mixed populations (Amann et al., 1990) and quantify messenger RNA. Combining flow 
cytometry with fluorescence in situ hybridisation (FISH) has generated a technique called Flow-FISH 
which can quantify fluorescent hybridization levels at the single cell level (Nettmann et al., 2013). 
These latter reporters have been used to investigate bacteria abundance or to distinguish specific 
properties of bacteria from environmental samples (Foladori et al., 2015;Wang et al., 2010;Decamp 
and Warren, 2001).  
1.6. Problem statement  
 
Treatment for drug susceptible TB lasts for at least six months in part due to the presence of a 
subpopulation of M. tuberculosis which is drug tolerant (Keren et al., 2011). The mechanisms which 
are responsible for this phenotype are unknown mainly because there are no methods for isolating this 
rare subpopulation of bacteria (Mouton et al., 2016;Grant et al., 2012). Identification of such 
subpopulations so that they can be characterized is a major challenge as they represent less than 2% of 
the bacterial population (Keren et al., 2004). Flow cytometry and fluorescent stains have been 
successfully used to distinguish physiological states of bacteria in environmental microbiology so we 




1.7. Research rationale 
 
The basis of this study was to develop an in vitro flow cytometry and fluorescent based technique for 
identifying and isolating M. tuberculosis persisters. As mentioned earlier, the major advantage of flow 
cytometry over other techniques like microscopy, plating for CFU and PCR is the rapid and accurate 
multiparameter analysis of many cells at single cell level. Fluorescent indicators are an established tool 
for distinguishing phenotypes at single cell level (Joux and Lebaron, 2000) however very few 
fluorescent stains have been used to study M. tuberculosis physiology. Bacterial flow cytometry is still 
developing and this study would be a significant advance in the field.  The ability to isolate antibiotic 
survivors will enable us to identify mechanisms which cause this phenotype and possibly new targets 
for TB drug development. This study may also result in the identification of new protocols for viability 
staining in M. tuberculosis. 
1.6. Hypothesis 
 
We hypothesised that fluorescent stains can be used to predict the viability of bacteria and FACS can 
be used to isolate antibiotic cell survivors in M. tuberculosis. This approach would enable us to 
characterize the physiological differences between antibiotic tolerant (viable) and susceptible (non-
viable) bacteria using for example transcriptomics, lipidomics and other techniques.  
1.6.1. Aims 
(i) To identify the fluorescent stains which can be used to predict the viability of antibiotic 
treated M. tuberculosis. 
(ii) To use FACS to isolate single cell antibiotic survivors in M. tuberculosis. 












MATERIALS AND METHODS 
2.1. Materials 
All chemical reagents and antibiotics were obtained from Sigma Aldrich. Fluorescent dyes were 
obtained from Life Technologies. All chemical reagents and antibiotics were of analytical grade. The 
centrifuge was from Beckman Coulter®. Liquid chromatography was done using C18 column-
ZORBAX Eclipse Plus C18 (2.1 mm x 50 mm; Agilent Technologies, USA) SN-USUX MO2122 and 
HILIC column-ZORBAX HILIC Plus (2.1 mm x 50 mm; Agilent Technologies, USA) SN-
USCJR01187. Mass Spectrometry was done using the Triple Quad instrument (AB Sciex QTrap® 
5500). Flow cytometry analysis and cell sorting was done using the BD FACS ARIA III cell sorter-
Special Order Research Product (BD Biosciences, USA) located in a biosafety cabinet at the KwaZulu 
Natal Research Institute for TB and HIV situated in a biosafety level 3 (BSL-3) laboratory. All work 
done with M. tuberculosis was done in a biosafety cabinet in the BSL-3 laboratories.  
2.2. Methods 
2.2.1. M. tuberculosis strain and culturing 
M. tuberculosis H37Rv strain was used in this project.  
2.2.1.1. Glycerol stocks preparation 
M. tuberculosis was grown to OD600 > 1 to ensure the cells were in stationary phase. Culture aliquots 
(1 mL) were added to 50% glycerol (500 µl) to make 25% glycerol stocks of the culture in cryovials. 
The stock culture was gently mixed by vortexing and stored at -80ºC.  
2.2.1.2. Culturing of M. tuberculosis from glycerol stock  
A cryovial containing 25% glycerol stock was thawed and added to a 30 mL inkwell containing 10 mL 
7H9 media supplemented with 10% oleic acid- albumin-dextrose-catalase (OADC), 0.5 % glycerol and 
0.05% Tween 80 (Appendix A). The culture was incubated at 37 ºC with shaking at 100 revolutions per 
minute for 7 days prior to sub culturing.   
2.2.2. Liquid Chromatography – Mass Spectrometry (LCMS) 
The stability of antibiotics was evaluated by monitoring the concentration of INH, RIF and ofloxacin 
(OFX) over 336 hours in 7H9 media and culture incubated at 37 ºC. Samples from both culture and 
media were analysed by liquid chromatography and mass spectrometry to measure the drug 
concentration. 
2.2.2.1. Culture preparation 
M. tuberculosis was sub cultured from a glycerol stock culture and grown to OD600 ~ 0.3. Culture 
aliquots (10 mL) were treated with either minimum inhibitory concentration (MIC) or 10X MIC of 




B. Media controls were prepared by adding the antibiotics to 10 mL of 7H9 supplemented with OADC. 
The experiment was done in triplicate and all inkwells were incubated at 37 °C with shaking for 336 
hours.  
2.2.2.2. Culture and media samples 
At baseline, 168 and 336 hours of incubation, 1 mL samples were taken in duplicate from each treatment 
condition for LCMS analysis. Culture samples were centrifuged at 10 000g for 10 minutes at room 
temperature to pellet the cells. The supernatant was filtered through a 0.2 micron filter into 1.5 mL 
Eppendorf tubes and samples were stored at -80 ºC. Media samples were filtered through 0.2 micron 
filters and stored at -80 ºC.   On the day of analysis samples from 10X MIC were diluted 10 fold. 
2.2.2.3. High Performance Liquid Chromatography (HPLC) and Mass Spectrometry 
Chromatography was done on a HILIC column with a mobile phase of 75% Acetonitrile (ACN) in water 
for INH and RIF samples. The internal standard was 6-amino-nicotinic acid. The sample was mixed 
with 100% ACN containing internal standard in a ratio of 1:2 and gently mixed by vortexing. The 
samples were centrifuged at 16 000 rpm for 7 minutes to pellet precipitated proteins. The supernatant 
was mixed with deionised water at a ratio of 4:1 in a sample vial. The sample vial was then loaded on 
the auto sampler. Chromatography for OFX samples was done on a C18 column with a mobile phase 
of 15% ACN in water using the same internal standard. OFX samples were prepared in the same manner 
as INH and RIF samples until centrifugation. The supernatant was mixed with deionised water at a ratio 
of 1:3 in a sample vial. The sample was injected into the respective column for separation by high 
performance liquid chromatography then the samples were directly injected into the mass spectrometer 
which is attached to the column. Here the sample was fragmented into ions with different transitions. 
The transitions for detection and analysis for INH, RIF and OFX were of m/z 138.118/93.000, 
823.280/791.400 and 361.958/318.100 respectively. Data acquisition, peak integration and calibration 
were performed using the Analyst software 1.6.2 (SCIEX, USA). Standard curves were generated to 
calculate the drug concentration in the samples.  
2.3. Viability staining 
2.3.1. Flow cytometry sample preparation and acquisition 
Staining was done using 1 mL aliquots from three biological replicates and each replicate was analysed 
by flow cytometry. Cells were filtered through a 10 micron filter prior to acquisition on the flow 
cytometer. Single cells were identified by exploiting the relationship between height and width in the 
forward and side scatter signals (Figure 3.2.). This gating strategy excluded doublets and was followed 
during acquisition and sorting on the BD DIVA Software (BD Biosciences). The cells were acquired at 
a threshold rate ~ 5000–7000 events per second and 100 000 events were recorded. Photomultiplier 





2.3.2. Evaluating antibiotic treated cells for esterase activity  
Optimisation of the calcein green and calcein blue staining protocols was done by Vanisha Munsamy 
and Pamla Govender. M. tuberculosis was grown to log phase (OD600 ~ 0.4) and treated with INH, 
EMB, clofazimine (CFZ) and RIF at 10X MIC and incubated at 37 ºC for 72 hours. At baseline, 24 and 
72 hours samples were stained with calcein blue or calcein green at 5 µg/mL for 1 hour at room 
temperature then filtered through a 10 micron filter and analysed on the BD FACS ARIA III. Calcein 
blue was excited with a 355 nm UV laser and fluorescence monitored using a DAPI filter. Calcein green 
was excited with a 488 nm laser and fluorescence intensity monitored using a FITC filter. We initially 
optimised the staining protocol by staining with FDA concentrations ranging from 0.01 – 10 µg/mL.  
FDA staining log phase cultures were treated with INH, RIF, moxifloxacin (MOX) and streptomycin 
(STR) at 10X MIC. At baseline, 72 and 168 hours samples were stained with FDA at 2.5 mg/mL for 1 
hour at room temperature then filtered and analysed on the BD FACS ARIA III. FDA was excited with 
a 488 nm blue laser and fluorescence monitored using the FITC filter. 
2.3.3. Analysis of membrane integrity and membrane potential after antibiotic treatment 
Membrane integrity was evaluated using propidium iodide and Sytox red. The staining protocol was 
optimised by Vanisha Munsamy and Pamla Govender.  M. tuberculosis was grown to log phase and 
treated with INH, EMB, CFZ and RIF at 10X MIC and incubated at 37 ºC for 72 hours. At baseline, 24 
and 72 hours samples were stained with propidium iodide at 2 µg/mL or Sytox red at 5 µg/mL for 1 
hour at room temperature then filtered and analysed on the BD FACS ARIA III. PI was excited with a 
561 nm yellow green laser and fluorescence monitored using a PI filter. Sytox red was excited with a 
640 nm red laser and fluorescence monitored using an Alexa Fluor 647 filter. 
We evaluated membrane polarity using DiOC2 (3) which emits both red and green fluorescence and 
DiBAC4(3) which emits green fluorescence. We modified the BacLight Bacterial Membrane Potential 
kit protocol (Thermo Fisher Scientific) for DiOC2 (3) staining.  We initially compared the membrane 
potential changes in log phase M. tuberculosis, E. coli and S. aureus by treating the cells with 10 µM 
CCCP for 30 minutes to depolarise the membrane. Untreated cells were used as the hyperpolarised 
control. Untreated cells and depolarised cells were stained with 15 µM DiOC2 (3) for 1 hour at room 
temperature then filtered and analysed on the flow cytometer. DiOC2 (3) was excited with a 488 nm 
blue laser and fluorescence monitored using the PercP-Cy5.5 (red) and Alexa Fluor 488 (green) filters. 
The median fluorescence intensity was used to calculate the red: green ratio. M. tuberculosis was grown 
to log phase and treated with INH, RIF, MOXI and STR at 10X MIC then stained with 15 µM DiOC2 
(3) for 1 hour at baseline, 24 and 72 hours. We optimised the DiBAC4 (3) staining protocol by staining 
bacteria with concentrations ranging from 0.03-10 µg/mL. Antibiotic treated samples were stained with 
0.05 µg/mL DiBAC4 (3) for 1 hour at room temperature then filtered and analysed. The depolarised 




suspending the pellet in 1 mL PBS. DiBAC4 (3) was excited with the 488 nm blue laser and fluorescence 
monitored using the FITC filter. 
2.3.4. Analysis of ROS formation using DHE and CellROX oxidative stress reagents  
Initially we optimised the concentrations for the positive control cumene hydroperoxide (CHP) which 
induces ROS formation and the negative control N-Acetyl-L-cysteine (NAC) which increases the anti-
oxidative capacity of the cells.  Cells were incubated with 5 mM CHP or 10 mM NAC for 1 hour at 
room temperature.  We then stained untreated cells with CellROX dyes at a final concentration of 5 µM 
according to the manufacturers protocol (Life Technologies) and incubated at room temperature for 
either 30 minutes or 1 hour. We compared CHP versus 5 mM tert-butyl-hydroperoxide (TBHP) as 
positive controls. We also compared the staining patterns with or without washing. Subsequently, we 
stained 1 mL of cells with 5 µM of CellROX reagent for 1 hour at room temperature. This was followed 
by a washing step in which the cells were centrifuged at 10 000g for 10 minutes then the pellet was re-
suspended in 1 mL of 7H9 media then filtered and analysed by flow cytometry.  
We next evaluated ROS formation after antibiotic treatment as a marker a potential marker for viability. 
Log phase cultures were treated with INH, EMB, CFZ, OFX, levofloxacin (LVX), MOX, STR and RIF 
at 10X MIC and incubated at 37 ºC for 72 hours. Samples were collected for staining with CellROX 
Deep red and CellROX green reagents at baseline, 3, 6, 24 and 72 hours. The staining protocol described 
above was performed followed by flow cytometry analysis. We also stained untreated cells with 
different concentrations of DHE ranging from 5-50 µM for 30 minutes or 1 hour at room temperature. 
We compared the flow cytometry analysis with or without a washing step after staining.  
2.3.5. Dual staining of calcein stains and membrane integrity stains 
We simultaneously evaluated the esterase activity and membrane integrity of antibiotic treated M. 
tuberculosis by staining with combinations of either calcein blue and Sytox red or calcein green and PI. 
Log phase cultures were treated with INH, EMB, CFZ and RIF at 10X MIC and incubated at 37 ºC for 
72 hours. At baseline, 24 and 72 hours samples were stained for 1 hour at room temperature then filtered 
through a 10 micron filter and analysed by flow cytometry. The same stain concentrations were used as 
with single staining and cytometer settings were not changed during acquisition. 
2.4. Evaluating fluorescent dyes as viability markers 
Initially we evaluated the effect of the fluorescent stains on the viability of untreated cells. Cells were 
grown to log phase and incubated with each stain at the appropriate concentration (Appendix D) for 1 
hour at room temperature. Staining was done in triplicate. The sorting protocol was done using the four-
way purity precision mode. Events were sorted into 2.5 mL Eppendorf tubes. The purity of sorted events 
was evaluated by reflowing a small proportion from the sorted events. The negative (low staining) 
subpopulation was collected from the events one log away from the positive (high staining) 




plated on Middlebrook 7H10 agar supplemented with 2.5% glycerol and 10% OADC. The plates were 
incubated for 21 days at 37 ºC.  Plates containing between 20-200 visible colonies were used to calculate 
the colony forming units (CFU) per mL.  
𝐶𝐹𝑈 𝑝𝑒𝑟 𝑚𝐿 =  𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 ×  𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 × 10 
 2.4.1. PI and Sytox red as viability markers 
We evaluated the ability of membrane integrity stains PI and Sytox red to detect non-viable bacteria 
after antibiotic treatment. We compared the differences in the culturability of PI negative versus PI 
positive bacteria and Sytox red negative versus Sytox red positive bacteria. We treated log phase cells 
with OFX, RIF and INH at 10X MIC then incubated at 37 °C with shaking. Samples were collected at 
baseline, 72 and 168 hours after treatment and stained with PI. We sorted 500 000 events from the PI 
negative and PI positive subpopulations into 2.5 mL Eppendorf tubes. The sorted events were 
centrifuged at 10 000g for 10 minutes and the pellet was then re-suspended in 150 µL 7H9 media. Serial 
dilutions were performed as shown in Figure 2.1 and 100 µL was plated from each dilution. Plates were 
checked for growth after 21 days of incubation at 37 °C.  
 
 
Figure 2.1. Schematic illustrating dilutions done after sorting. After sorting of required events and 
centrifugation the pellet was re-suspended in 7H9 media (neat). Tenfold dilutions were done using 7H9 media 
followed by plating. 
CFU was calculated as shown below. Growth ratio was calculated by dividing the CFU by the number 
of sorted events. The ratio of survival of PI positive cells to PI negative cells was calculated as shown 
below.  This ratio was calculated separately for each antibiotic and at each time point. 
𝐶𝐹𝑈 =  𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 ×  𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 × 1.5 
𝐺𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑖𝑜 =
𝐶𝐹𝑈





𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 𝑜𝑓 𝑃𝐼 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑡𝑜 𝑃𝐼 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒
=
𝑀𝑒𝑎𝑛 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝑃𝐼 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 ( 𝑡 = 𝑥)
𝑀𝑒𝑎𝑛 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝑃𝐼 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 ( 𝑡 = 𝑥)
 
We also treated log phase bacteria with RIF and OFX at 10X MIC then incubated at 37 °C with shaking. 
Samples were collected at baseline, 24 and 72 hours after treatment and stained with Sytox red. We 
sorted 250 000 events from the Sytox red negative and Sytox red positive subpopulations into 2.5 mL 
Eppendorf tubes. Sorted events were treated as previously described and plated. Plates were incubated 
at 37 °C for 21 days and checked for CFUs. CFU and growth ratio were calculated as described above. 
The ratio of survival of Sytox red positive cells to Sytox red negative cells was calculated as shown 
below. 
𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 𝑜𝑓 𝑆𝑦𝑡𝑜𝑥 𝑟𝑒𝑑 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑡𝑜 𝑆𝑦𝑡𝑜𝑥 𝑟𝑒𝑑 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒
=
𝑀𝑒𝑎𝑛 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝑆𝑦𝑡𝑜𝑥 𝑟𝑒𝑑 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 ( 𝑡 = 𝑥)
𝑀𝑒𝑎𝑛 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝑆𝑦𝑡𝑜𝑥 𝑟𝑒𝑑 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 ( 𝑡 = 𝑥)
 
 
2.4.2. Calcein blue as a viability marker 
We next analysed if the presence or absence of metabolic activity could be used to identify viable 
bacteria after antibiotic treatment. To carry out this aim, log phase bacteria were treated with CFZ and 
RIF at 10X MIC then incubated at 37 °C with shaking. Samples were collected at baseline, 24 and 72 
hours after treatment and stained with calcein blue. We sorted 250 000 events from the calcein blue 
negative and calcein blue positive subpopulations into 2.5 mL Eppendorf tubes. Sorted events were 
treated as previously described and plated. Plates were incubated at 37 °C for 21 days and checked for 
CFUs. CFU and growth ratio were calculated as described above. The ratio of survival of calcein blue 
negative cells to calcein blue positive cells was calculated as shown below. 
𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 𝑜𝑓 𝐶𝑎𝑙𝑐𝑒𝑖𝑛 𝑏𝑙𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑡𝑜 𝐶𝑎𝑙𝑐𝑒𝑖𝑛 𝑏𝑙𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒
=
𝑀𝑒𝑎𝑛 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝐶𝑎𝑙𝑐𝑒𝑖𝑛 𝑏𝑙𝑢𝑒  𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 ( 𝑡 = 𝑥)
𝑀𝑒𝑎𝑛 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝐶𝑎𝑙𝑐𝑒𝑖𝑛 𝑏𝑙𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 ( 𝑡 = 𝑥)
 
2.4.3. CellROX Deep red as a viability marker 
We finally evaluated if the presence of ROS would be in indicator of cell death. We did this by treating 
log phase bacteria with CFZ and RIF at 10X MIC then incubated at 37 °C with shaking. Samples were 
collected at baseline, 24 and 72 hours after treatment and stained with calcein blue. We sorted 250 000 
events from the CellROX Deep red negative and CellROX Deep red positive subpopulations into 2.5 
mL Eppendorf tubes. Sorted events were treated as previously described and plated. Plates were 
incubated at 37 °C for 21 days and checked for CFUs. CFU and growth ratio were calculated as 
described above. The ratio of survival of CellROX Deep red positive cells to CellROX Deep red 




𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 𝑜𝑓 𝐶𝑒𝑙𝑙𝑅𝑂𝑋 𝑑𝑒𝑒𝑝 𝑟𝑒𝑑 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑡𝑜 𝐶𝑒𝑙𝑙𝑅𝑂𝑋 𝐷𝑒𝑒𝑝 𝑟𝑒𝑑 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒
=
𝑀𝑒𝑎𝑛 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝐶𝑒𝑙𝑙𝑅𝑂𝑋 𝐷𝑒𝑒𝑝 𝑟𝑒𝑑 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 ( 𝑡 = 𝑥)
𝑀𝑒𝑎𝑛 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝐶𝑒𝑙𝑙𝑅𝑂𝑋 𝐷𝑒𝑒𝑝 𝑟𝑒𝑑 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 ( 𝑡 = 𝑥)
 
2.5. Flow cytometry and Statistical analysis 
The same gating strategy used during acquisition was used during analysis of FCS files using FlowJo 
versions 9 and 10 (Tree Star, OR, USA). GraphPad Prism 6 was used for statistical analysis. Multiple 








3.1. Mass spectrometry analysis of drug stability 
We initially sought to establish the stability of antibiotics in culture and media at different 
concentrations. Too low a concentration might result in selection of resistant mutants over the longer 
time courses required to study phenotypic tolerance, especially if drugs were labile in culture conditions. 
This would also enable us to determine the duration of treatment for these drugs. Other drugs were used 
in this study but we selected INH that is known to be unstable, RIF and OFX. We used these antibiotics 
to define a concentration relative to MIC that could be applied for many drugs. 
We found OFX to be stable in both media and culture at 37 ºC for at least 336 hours. In contrast, RIF 
and INH exhibited a decrease in the drug concentration with time during culture and with media alone. 
The results were similar at both concentrations (at 1X MIC and 10X MIC) for all the antibiotics. Based 
on these results we decided to use 10X MIC for all antibiotics and treat for at most 168 hours without 
adding more antibiotic.  
 
Figure 3.1. Assessing antibiotic stability over time in media and in culture. Cells or 7H9 media were incubated 
at 37 °C with antibiotic at 1X MIC or 10X MIC in triplicate. Antibiotic concentration was measured by collecting 
samples after 168 and 336 hours of incubation then analysed by mass spectrometry. There was a 90% decrease in 
the concentration of INH and RIF after 336 hours. However, the concentration of OFX was stable over the 336 
hours of incubation. The log change in concentration was calculated as a fraction of the baseline concentration (y 






3.2. Staining patterns of drug treated cells 
Antibiotic treated cells were stained with a range of fluorescent stains which measure enzyme activity, 
membrane integrity, membrane potential and oxidative stress. These stains were either used alone or in 
conjunction with others. The gating strategy was specific for single cells during acquisition on the BD 
DIVA software and during analysis of fcs files in FlowJo (Figure 3.2.). The doublet bacteria were 
excluded from analysis based on the relationship between height and width in the forward and side 
scatter signals.  In preliminary experiments done in the laboratory this strategy was shown to exclude 
doublets using M. tuberculosis expressing red and green fluorescent proteins. The same strategy was 
used in subsequent analysis.  
 
 
Figure 3.2. The gating strategy used to analyse flow cytometry files and define single cells. The total 
population was gated on the relationship between cell size (forward scatter - FCS) and granularity (side scatter - 
SSC). Doublets were excluded by gating twice on the single cells using the width to height relationship in both 
FCS and SSC. The green  to red area shows the highest cell density. SSC-H – side scatter height, SSC-W – side 
scatter width, FSC-H – forward scatter height, FSC-W – forward scatter width. 
3.2.1. Esterase activity stains 
 
We evaluated calcein blue, calcein green and FDA for non- specific esterase enzyme activity. These 
fluorescent stains are thought to enter cells passively after which the activity of intracellular bacterial 
esterases cleave acetoxymethyl ester groups resulting in fluorescence. The continued presence of 
esterase activity after drug treatment could indicate viability. In untreated cells, we observed very 
similar bimodal patterns for both calcein green and calcein blue with approximately 60% cells positive 
for either stain, relative to unstained controls. After drug treatment, we observed marked drug specific 
staining patterns and considerable heterogeneity (Figure 3.3.; Figure 3.4. and Figure 3.5). There was no 
difference between calcein blue and green staining patterns after treatment with INH, EMB, CFZ and 
RIF at all time points. Strikingly for INH and EMB nearly all cells became calcein blue or green positive 
after 24 and 72 hours of treatment indicating the presence of ongoing esterase activity in all cells. In 
contrast the staining patterns for CFZ and RIF treated cells changed less with a slight reduction in the 






Figure 3.3. Evaluation of esterase activity using calcein blue. Cells were stained in triplicate with calcein blue 
as a measure of esterase activity after 24 and 72 hours of drug treatment. The histograms show that INH and EMB 
treatment causes the entire population to become calcein blue positive. RIF and CFZ treatment results in a small 
decrease in the calcein blue positive subpopulation. The fluorescence intensity of calcein blue (x axis) was 
measured with the DAPI filter. The y axis shows the cell count. Gates are based on the unstained control. The 






Figure 3.4. Evaluation of esterase activity using calcein green.  Cells were stained in triplicate with calcein 
green as a measure of esterase activity after 24 and 72 hours of drug treatment. The histograms show that INH 
and EMB treatment caused all cells to be calcein green positive. RIF and CFZ treatment resulted in a slight 
decrease in the calcein green positive subpopulation. The y axis shows the cell count and the x axis shows the 
calcein green intensity measured with the FITC filter. Gates are based on the unstained control.  The numbers 
show the percentages of the calcein green negative and calcein green positive subpopulations respectively.  
  
We then evaluated FDA staining, which also depends on the same esterases for fluorescent activation. 
Interestingly in contrast to the calcein stains all cells were positive for FDA staining in the absence of 
drug although there was marked heterogeneity in the intensity of fluorescence (Figure 3.5).  After 
treatment, the changes in staining patterns with FDA were roughly similar to those found with the 
calcein stains. In the case of INH treated cells there was an increase in staining and a reduction in 
heterogeneity indicated by a narrowing in the peak width. After treatment with the other drugs (RIF, 
MOX, STR) most the cells remained positive for FDA staining but there was a slight decrease in the 
mean fluorescent intensity. Taken together these results indicate that staining for esterase activity within 
72 hours of treatment is drug specific. The increase in staining observed with cell wall synthesis 
inhibitors such as INH and EMB, in contrast to drugs with other modes of action, suggests that changes 








Figure 3.5. Evaluation of esterase activity using FDA.  Cells were stained in triplicate with FDA to measure 
esterase activity after 72 and 168 hours of drug treatment. All cells were positive at baseline and approximately 
90% of cells remained positive after 168 hours of antibiotic treatment. There was a reduction in the heterogeneity 
of staining in INH treated cells. FDA fluorescence intensity (x-axis) was measured with the FITC filter. The y 
axis shows the cell count. Gates are based on the unstained control. The numbers represent the percentages of the 
FDA negative and FDA positive subpopulations.  
3.3.2. Membrane integrity and membrane potential stains 
Positively charged stains that fluoresce on binding to DNA, but are excluded from cells that have intact 
membranes, have been used successfully as viability markers in other microorganisms.  To evaluate 
two such “membrane integrity” markers, we compared the staining patterns of PI and Sytox red after 
treatment with drugs. In the absence of drug less than 5% of cells stained positively for PI. Surprisingly 
the proportion of cells positive for PI did not substantially increase after treatment with EMB, RIF, CFZ 
or INH with the PI positive population greatest after treatment with EMB. Remarkably for all the treated 
cultures, most of the cells were PI negative after 72 hours suggesting that the cells still had intact 







Figure 3.6. Membrane integrity assessment after antibiotic treatment using PI. Cells were stained in triplicate 
with PI to measure of membrane integrity after 24 and 72 hours of drug treatment. There was a general increase 
in the PI positive population with EMB treated cells producing the highest percent increase. There was no change 
in the PI staining patterns after INH treatment relative to baseline. The fluorescence intensity of PI (x axis) was 
measured using the PI filter. The y axis shows the cell count. Gates are based on the unstained control. The 
numbers show the percentages of the PI negative and PI positive subpopulations respectively.   
Like PI staining, we also observed similar patterns of staining with Sytox red. Baseline staining resulted 
in a slight right shift in the overall staining but also a distinct small subpopulation with high staining. 
The gating was based on the untreated (T= 0) because the unstained and untreated were not similar as 
observed with PI. RIF and CFZ treated cells produced similar staining patterns (Figure 3.7). Although 
both EMB and INH target cell wall synthesis, EMB treated cells produced two distinct subpopulations 
whereas with INH treated cultures there was a general shift of the entire population to the right. The 
staining patterns at baseline suggested that the cell membrane was approximately five times more 
permeable to Sytox red than PI. Hence the percentages of Sytox red positive cells at all time points were 
higher than the corresponding PI positive. Despite this minor difference between the two stains, we 








Figure 3.7. Evaluating membrane integrity after antibiotic treatment using Sytox red. Cells were stained in 
triplicate with Sytox red to measure membrane integrity after 24 and 72 hours of drug treatment. There was a 
general shift towards positivity in the overall staining at all timepoints. However, there were distinct low and high 
staining cells after EMB treatment. The histograms are showing changes in the fluorescence intensity of Sytox 
red (x axis) measured with the Alexa Fluor 647 filter. The y axis shows the cell count. Gates are based on the 
untreated control (T =0). The numbers show the percentages of Sytox red negative and Sytox red positive cells. 
PI and Sytox red are indirect measures of membrane polarity, in that their exclusion from cells is partly 
due to their polarity. Other stains were used to measure membrane polarity more directly i.e. DiOC2 
(3). To determine if DiOC2 (3) could be used in Mycobacteria we compared the differences between 
depolarised and hyperpolarised cells in M. tuberculosis staining with E. coli and S. aureus. DiOC2 (3) 
is thought to bind to the inner membrane and emits a red-green fluorescence. After depolarization, the 
dye is more diffusely bound resulting in a decreased emission in the red spectrum. Thus, depolarisation 
is detected by a reduction in the red to green fluorescent ratio. With S. aureus, we found a six-fold 
reduction in the red to green ratio as described previously for this assay. In contrast, there were only 
subtle changes in the red: green ratio of depolarised and hyperpolarised cells for E. coli and M. 







Figure 3.8. Comparing membrane potential changes between M. tuberculosis and other bacteria. Cells were 
stained in triplicate with DiOC2 (3) to evaluate changes in membrane potential. The red: green ratio was calculated 
by dividing the median of the red fluorescence by the median of the green fluorescence. S. aureus had the highest 
difference between polarised (untreated) and depolarised cells (CCCP treated). There was a very small difference 
in the red: green ratio of M. tuberculosis and E. coli. Error bars represent standard deviation. 
Although there were only subtle changes in the fluorescent ratio after depolarization we decided to 
evaluate if these changes could be used to identify potentially viable organisms after drug treatment. 
For the five drugs tested there was a modest paradoxical increase in the red: green ratio, rather than 
decrease as would be expected in a depolarized membrane. The largest effect was seen after INH 
treatment (Figure 3.9). We further analysed this by doing a dot plot for the INH treated cells. This 
showed that there was an increase in the red as well as green emission spectra (Figure 3.10). This might 
be due to the mechanism of action of INH on the cell wall that alter stain penetration, similar to that 








Figure 3.9. Analysis of changes in membrane polarity after drug treatment using DiOC2 (3).  Cells were 
stained in triplicate with DiOC2 (3) to evaluate changes in membrane potential after 24 and 72 hours of drug 
treatment. The red: green ratio was calculated by dividing the median of the red fluorescence by the median of 
the green fluorescence.  The red: green ratio generally increased with antibiotic treatment and INH treatment 







Figure 3.10. Overlays of dot plot diagrams showing the differences between polarised and depolarised cells. 
Cells were depolarised by incubating with CCCP for 30 minutes or treated with INH for 24 hours. Cells were 
stained in triplicate with DiOC2 (3) to measure the changes in membrane polarity compared with the untreated. 
DiOC2 (3) staining produces red fluorescence (y axis) and green fluorescence (x axis). The overlays show that 
there was heterogeneity in staining and no clear difference in the localisation of polarised cells and depolarised 
cells in M. tuberculosis. INH treatment caused both the red and green fluorescence to increase compared to the 
untreated. 
We also stained cells with DiBAC4 (3), another dye with single colour fluorescence which has been 
used to detect changes in membrane polarity. Heat killed cells were the depolarised control and 
untreated cells were the hyperpolarised control, although there was only a modest increase in 
fluorescence in the heat treat control. Like DiOC2 (3), there were minimal changes after antibiotic 






Figure 3.11. Evaluating membrane polarity after antibiotic treatment using DiBAC4 (3). Cells were stained 
in triplicate with DiBAC4 (3) to measure changes in membrane potential after 72 hours of drug treatment. The 
histograms show that there was a slight change in the fluorescence intensity of DiBAC4 (3) in heat killed and drug 
treated cells compared to the untreated (T = 0).  The y axis shows the cell count and x axis shows DiBAC4 (3) 
fluorescence intensity measured with the FITC filter. The gates were based on the untreated. The numbers show 
the percentages of the DiBAC4 (3) negative and DiBAC4 (3) positive subpopulations respectively. 
3.3.3. Oxidative stress stains 
Previous studies in E. coli have suggested that the generation of ROS in bacteria may precede killing 
by many antibiotics. We therefore decided to evaluate antibiotic treated cells for the presence of ROS 
as a potential marker of viability using fluorescent stains which can detect ROS. We hypothesized that 
antibiotic survivors would be negative or have lower levels of oxidative stress after antibiotic therapy. 
We initially stained with DHE but were unable to establish a low concentration of DHE to distinguish 
between induced oxidative stress (CHP treated) and cells treated with an antioxidant (NAC treated) 
(Figure 3.12.I). However, CellROX dyes produced staining patterns which could differentiate between 
cells undergoing oxidative stress (CHP treated) and untreated cells (Figure 3.12.II). We observed that 
CHP produced stronger fluorescence than TBHP with all the CellROX dyes tested. CellROX Deep red 
produced a more reproducible and intense fluorescent signal than CellROX Green with CHP (Figure 












Figure 3.12. Comparison of DHE, CellROX Deep red and Green in detecting oxidative stress. Cells were 
stained in triplicate with ROS detecting dyes (DHE, CellROX Deep red and CellROX green) to identify the best 
dye to use.   (I) There was no clear-cut distinction between the positive control (CHP) and the negative controls 
(NAC and untreated) at all DHE concentrations. (II) CellROX stains produced a better distinction between the 
controls and unstained sample. (III) CellROX Deep red produced a better fluorescent intensity than CellROX 
Green and CHP was a better positive control than TBHP. The y axis on the histograms in I and II shows the 
percentage of cells normalised to mode. The x axis shows the DHE fluorescence measured with the PerCP-Cy5.5 
filter (I), CellROX Green, Deep red and Orange fluorescence measured with FITC, APC and PE filters 





Figure 3.13.  Evaluating ROS production by anti-TB drugs using CellROX Deep red. Cells were stained in 
triplicate with CellROX Deep red to measure ROS production after 24 and 72 hours of drug treatment. (I) The 
overlay shows the high fluorescent intensity observed with CHP the positive control. (II) The histograms show 
that there were very subtle changes in the fluorescence intensity after treatment with fluoroquinolones (LVX, 
MOXI and OFX). (III) There was a great increase in the CellROX Deep red fluorescence intensity after CFZ and 
INH treatment. There were minimal changes in the fluorescence intensity after STR and RIF treatment. The y axis 
shows the percentage of cells normalised to mode. The x axis shows the CellROX Deep red fluorescence intensity 
measured with the APC filter.  
We then evaluated the generation of ROS after antibiotic treatment.  Cells were stained at earlier time 
points i.e. 3 and 6 hours after addition of drugs but there were no changes in the signal intensity relative 
to baseline therefore we only presented data for the 24 and 72 hour time points.  Treatment of M. 
tuberculosis with the fluoroquinolones resulted in very subtle changes in the CellROX Deep red 
fluorescence intensity which suggested that these antibiotics may not result in the production of ROS 




cultures suggesting that ROS were formed in a time dependant manner (Figure 3.13.III, Appendix E). 
This suggests that these antibiotics might produce ROS as part of their bactericidal activity.  There were 
minimal changes in the fluorescence intensity of CellROX Deep red staining after STR and RIF 
treatment.  
3.5. Multi-parameter analysis 




Figure 3.14. Dual staining with calcein green and PI. Cells were stained in triplicate with calcein green and PI 
to evaluate esterase activity and membrane integrity after 24 and 72 hours of drug treatment. The dot plots show 
that all cells are calcein green positive after INH and EMB treated cultures. However, an increase in the dual 
positive subpopulation was only observed in EMB treated cells. CFZ and RIF treated cells produced similar 
staining patterns with approximately 50% of the population being calcein green and PI negative. There was a 
slight increase in the PI positive subpopulation. The y axis shows calcein green fluorescence intensity and the x 
axis shows PI fluorescence intensity. Gates were based on the unstained control. The numbers show the 
percentages of cells in the respective gates.  
In order to increase our ability to identify subpopulations of potentially viable organisms we then 
decided to combine stains. We reasoned that if high PI staining and reduced esterase activity were 




then there may be an enrichment of high PI staining in the calcein negative population.   Dual staining 
of antibiotic treated cells with fluorescent dyes that detect esterase activity and membrane integrity was 
carried out using the same protocols as before. The results were similar with single staining. In the case 
of INH and EMB we observed high calcein staining and a small subpopulation of 2.3% and 13.8 that 
were dual stain with each drug respectively. In contrast with CFZ and RIF there 4 distinct populations 
after drug treatment with double positive and negative staining as well as staining for either calcein or 
PI. These observations were similar for cells stained with either calcein green and PI (Figure 3.14) and 
calcein blue and Sytox red (Figure 3.15). The presence of a PI or Sytox red positive population that 
were negatively stained for calcein suggested these may be a marker of non-viability, although this 
population was very small. The marked differences in staining after treatment with different drugs also 
suggests that the mechanisms of antibiotic survival may differ depending on the antibiotic used for 
treatment. The marked heterogeneity of staining may also indicate that many distinct subpopulations of 














Figure 3.15. Dual staining with calcein blue and Sytox red. Cells were stained in triplicate with calcein blue 
and Sytox red to evaluate esterase activity and membrane integrity after 24 and 72 hours of drug treatment. All 
cells were positive for calcein blue after INH and EMB treated cultures.  Only EMB treated cells resulted in an 
increase in the dual positive population. CFZ and RIF treated cells produced similar staining patterns with 
approximately equal distribution of the cells in calcein blue negative and calcein blue positive subpopulations. 
Approximately 10% of the cells were Sytox red positive after 72 hours of drug treatment. The y axis shows calcein 
blue fluorescence intensity and the x axis shows Sytox red fluorescence intensity. Gates were based on the 
untreated control (T = 0). The numbers show the percentages of cells in the respective gates. 
3.6. Evaluation of fluorescent stains as viability markers 
3.6.1. The effect of fluorescent stains on viability. 
Having defined subpopulations of differentially stained bacteria after antibiotic treatment we then 
decided to assess if there would be any differences in the survival of the different subpopulations. Before 
evaluating the differences in survival between stained subpopulations from treated cells, we sought to 
verify the effect of fluorescent dyes on the viability of untreated cells. Figure 3.16 shows that there were 





Figure 3.16. Analysing the effect of fluorescent dyes on the viability of untreated cells. Cells were stained in 
triplicate with fluorescent dyes for 1 hour then plated for CFU using the dilution method. There was no significant 
difference ( P > 0.05) between the survival of the stained cells and the unstained cells.  The fold change in survival 
was calculated by dividing the mean of the stained by the unstained. CB – Calcein blue, PI – Propidium iodide, 





3.6.2. Evaluating membrane integrity stains as viability markers 
 
In our first experiment, we evaluated if bacteria that were positive for PI staining have reduced 
culturability.  After treating with antibiotics for 72 and 168 hours bacteria were stained with PI and 
sorted on the basis of two gates corresponding to PI negative and positive. The gating for the negative 
population was based on the staining prior to treatment.  Sorted bacteria were plated and the CFU was 
calculated. We then calculated a survival ratio for PI positive cells to PI negative cells.  Despite the 
variation in staining patterns, mechanism of action and kill kinetics of the different antibiotics, we 
observed similar results when we evaluated the survival of the different subpopulations. There were no 
statistically significant differences in survival between the PI positive and PI negative subpopulations 
(Figure 3. 17). However, after 168 hours there was a trend towards less survival in the treatment with 
RIF and INH, the PI negative subpopulations but not with OFX. These results suggest that PI staining, 
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Figure 3.17. Evaluating Propidium iodide as a viability marker. Cells were stained in triplicate with PI to 
measure membrane integrity after 72 and 168 hours of antibiotic treatment. Equal numbers of events were sorted 
from the PI negative and PI positive subpopulations and plated for CFU.  (I) The percentage of cells in the PI 
positive subpopulation increased with antibiotic treatment. Approximately 50% of the cells were PI positive after 
168 hours of OFX treatment. (II)There were no significant differences between the survival of cells from the PI 




We then repeated the experiment with Sytox red. We observed similar results for both RIF and OFX 
treated cultures (Figure 3. 18). This observation supports our interpretation that dye uptake does not 




Figure 3.18. Evaluating Sytox red as a viability marker. Cells were stained in triplicate with Sytox red to 
measure membrane integrity after 24 and 72 hours of antibiotic treatment. Equal numbers of events were sorted 
from the Sytox red negative and Sytox red positive subpopulations and plated for CFU. (I) The percentage of cells 
in the Sytox red positive subpopulation increased with time. The percentage of cells that were PI positive after 
OFX treatment was twice that of RIF treated cells. (II) At baseline both subpopulations are equally enriched for 
survivors. After 24 and 72 hours of drug treatment, there were no significant differences between the survival of 
Sytox red positive and negative subpopulations. P values > 0.05. Error bars represent standard deviation. 
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3.6.3. Evaluating Calcein blue as a viability marker 
We next employed the same strategy to determine if different degrees of calcein staining associated 
with culturability after antibiotic treatment. We compared the difference in survival between calcein 
blue positive and calcein blue negative subpopulations. We observed that at baseline, both populations 
had equal numbers of survivors. After 24 hours of treatment there were no significant differences in the 




Figure 3.19. Evaluating calcein blue as a viability marker. Cells were stained in triplicate with calcein blue to 
measure esterase activity after 24 and 72 hours of antibiotic treatment. Equal numbers of events were sorted from 
the calcein blue negative and calcein blue positive subpopulations and plated for CFU. (I) There was a lot of 
heterogeneity in calcein blue staining and most of the cells were negative for calcein blue at all timepoints after 
RIF and CFZ treatment. (II) At baseline, there were equal chances of survival between the calcein blue positive 
and calcein blue negative population. There was no significant difference between the survival of the calcein blue 
negative and positive subpopulations after CFZ and RIF treatment. P values > 0.05. Error bars represent standard 
deviation. 
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3.6.4. Evaluating CellROX as a viability marker 
We compared the survival between CellROX Deep red low and high staining bacteria by sorting and 
plating. These we classified as CellROX negative and CellROX positive respectively based on the 
stained baseline cells. Just like we observed with PI and Sytox red staining at baseline there was more 
survival in the CellROX positive subpopulation (Figure 3.20). Similar results were observed in RIF 
treated cells at all timepoints. However, after 24 hours of CFZ treatment there was a slight difference 
in the survival of the CellROX negative subpopulation as determined by comparing the survival ratios 










Figure 3.20. Evaluating CellROX Deep red as a marker of viability. Cells were stained in triplicate with 
CellROX Deep red to measure esterase activity after 24 and 72 hours of antibiotic treatment. Equal numbers of 
events were sorted from the CellROX deep red negative and CellROX deep red positive subpopulations and 
plated for CFU. (I)The staining patterns were drug dependant with the major increase in signal intensity 
occurring after 72 hours of antibiotic treatment.  (II) At baseline and after 72 hours of antibiotic treatment, there 
were no significant differences (P > 0.05) in survival between the CellROX negative and positive 
subpopulations. However, after 24 hours of CFZ treatment, the CellROX negative subpopulation was enriched 
for survivors. * significant, P = 0.033. Error bars represent standard deviation. 
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It has been proposed that the prolonged chemotherapy for drug susceptible TB is due in part to a rare 
M. tuberculosis subpopulation which is drug tolerant (Keren et al., 2011). It is still not clear how a small 
fraction of bacteria (antibiotic survivors) can evade lengthy exposure to anti-TB drugs. Characterisation 
of this phenotype will require the identification and isolation of these antibiotic survivors.  We 
hypothesised that FACS can be used to identify and isolate this subpopulation and this would eventually 
lead to the identification of cellular mechanisms responsible for the formation of this phenotype. In our 
approach, we first sought to identify fluorescent dyes which would distinguish viable from non-viable 
bacteria after antibiotic treatment. This was done by staining antibiotic treated M. tuberculosis with 
fluorescent dyes which measure different aspects of cell viability including enzyme activity, membrane 
integrity and membrane polarity.  
We observed that staining patterns were drug specific and there was a phenotypic heterogeneity in the 
treated and untreated populations. Phenotypic heterogeneity refers to marked variability in phenotypic 
traits among a population of genetically identical microorganisms (Ackermann, 2015). We observed 
both aspects for most of the dyes that we tested regardless of the physiological aspect they were 
measuring. 
The evaluation of esterase dyes for viability staining showed that at baseline, most cells were calcein 
positive suggesting esterase activity was present however a significant proportion of the cells were 
calcein negative (Figures 3.3 and 3.4). This could have been due to reduced cell wall permeability to 
calcein dyes or efflux activity. The latter is likely to be the cause since the M. tuberculosis genome is 
known to encode for many efflux pumps which are actively involved in the extrusion of a wide variety 
of chemical compounds (Cole et al., 1998;De Rossi et al., 2006;Viveiros et al., 2012). This has 
implications for the staining patterns we observed because we were not sure if the cells that were 
staining negative for the cell permeant calcein dyes indicated lack of esterase activity or efflux activity. 
However, with FDA, which also requires esterase activity for fluorescence, we found that a greater 
proportion of cells stained positive which would suggest that variable esterase activity is not the driver 
of the heterogeneity we saw with calcein stains in untreated populations. Our results are different from 
Hendon-Dunn et al. (2016) who observed that all cells were calcein violet positive at baseline. This 
could be due to the differences in staining protocols i.e. concentrations of the dyes, duration of staining 
and formaldehyde fixing of cells. Formaldehyde fixing has been shown to cause changes in cell 
membrane which may cause the membrane to be more permeable (Günther et al., 2008;Bullock, 1984). 
Our approach was to develop stains for detecting viability so we were not interested in using 




settings and differences in hardware associated variables also present a challenge when comparing 
results across platforms and biological samples (Maecker and Trotter, 2006).  
After INH and EMB treatment all cells still had a paradoxical increase in esterase activity with all cells 
staining positive with calcein blue and calcein green. In contrast, for RIF and CFZ treatment a large 
proportion of cells stained negative for both calcein dyes (Figure 3.3 and Figure 3.4). We were not 
surprised to see that all cells stained positive for calcein after INH and EMB treatment since these drugs 
target the cell wall. This could have resulted in increased permeability of the cell wall to the dyes. Apart 
from the differences at baseline, Hendon-Dunn et al. (2016) also observed that a proportion of cells 
remained calcein positive in the first 72 hours of INH and RIF treatment.  Based on the assumption that 
cells lacking esterase activity (calcein negative) will not be viable, we sorted calcein blue negative and 
positive subpopulations to compare their survival. We observed that were no differences in the survival 
of both subpopulations before and after antibiotic treatment (Figure 3.19). The heterogeneity we 
observed with the calcein dyes and FDA staining (Figure 3.5) is a phenomenon which has been observed 
in many bacteria and eukaryotes. This variation is thought to arise due to differences in protein 
expression and function (Newman et al., 2006). Further studies are required to understand the molecular 
mechanisms of variation in calcein staining and to determine if the differences are due to gene or protein 
expression. The heterogeneity in staining we report here highlights the challenges of understanding 
processes at the single cell level and emphasizes that limitations of analysis at the population level 
largely ignore such variability (Honeyborne et al., 2016;Kaern et al., 2005).  
When we stained with PI and Sytox red we also observed drug specific staining patterns. It was 
encouraging to note that most cells were negative for these dyes at baseline because they are cell 
impermeant dyes which measure membrane integrity (Bunthof et al., 2001;Khan et al., 2010). The small 
number of cells that were positive in the absence of drug could be due to some cell death during 
logarithmic growth or that different stages of the cell division may be associated with changes in 
membrane permeability. 
After INH treatment there were slight changes in the proportion of cells that stained positive with PI. 
Although many cells stained negative for PI and Sytox, there was an increase in the number of cells that 
stained positive after EMB, RIF and CFZ treatment (Figure 3.4 and Figure 3.5). This suggested that 
most of the cells had intact cell membranes after 72 hours of drug treatment. Another explanation would 
be reduced cell membrane permeability to these dyes because as cells enter a state with changes to the 
cell wall. Stationary phase and stressed M. tuberculosis cells have been shown to exhibit changes in cell 
wall metabolism which may result in thickening and reduced permeability to antibiotics (Betts et al., 
2002;Xie et al., 2005;Bhamidi et al., 2012;Sarathy et al., 2013;Boutte et al., 2016).  
When we compared the different PI and Sytox red subpopulations, there were no significant differences 




dyes are not viability markers. PI may be a good dye for identifying cell damage (Soejima et al., 2009) 
but a poor indicator of cell death. It has been shown previously in some other bacteria which were 
stained with PI that there was no difference in survival between PI positive and PI negative 
subpopulations (Amor et al., 2002). We have also shown that this observation is true with M. 
tuberculosis at least after 72 hours of treatment.  
DiOC2 (3) and DiBAC4 (3) gave poor signals of depolarisation so we were not able to distinguish cells 
with depolarised membranes from those with hyperpolarised membranes (Figure 3.8 and Figure 3.11). 
Antibiotic treatment caused the red: green ratio to increase suggesting that cell membrane was still 
hyperpolarised (Figure 3.9) although we cannot rule out that drugs may have altered the interaction of 
the dyes with the cell membrane independently of polarisation. The sensitivity of the assay using these 
dyes, as determined in our control experiments, may also have been too low to detect subtle changes in 
membrane polarity. Antibiotics may also cause the cells to become more permeable to the dye hence 
the increase in the red: green ratio with INH producing a highest increase. 
DiOC2 (3) and DiBAC4 (3) have been successfully used to differentiate depolarised cells from 
hyperpolarised cells in Gram positive bacteria (David et al., 2012;Neumeyer et al., 2013;Nuding and 
Zabel, 2013). We confirmed this as S. aureus, a Gram positive bacteria produced a remarkable shift in 
the red: green fluorescence ratio compared to the Gram negative E. coli and M. tuberculosis when 
treated with CCCP as also noted by Chawla and Singh (2013). In another study, it has also been shown 
that anti-tubercular drugs bedaquiline and Q203 do not depolarise the M. tuberculosis membrane 
(Lamprecht et al., 2016). Based on these observations the outer membrane on E. coli and M. 
tuberculosis seems to affect dye activity showing that using fluorescent dyes may not be ideal for 
tracking membrane potential as a marker of viability in such bacteria.  
Grant et al. (2012) has shown that bacterial persisters can be eradicated using hydroxyl radicals 
generated by antibiotics. We evaluated production of ROS by anti-TB drugs using CellROX dyes. 
Although both CellROX Deep red and CellROX green detect hydroxyl and superoxide radicals, 
CellROX deep red gave the strongest signal with CHP treatment suggesting it was the best of our stains 
for detecting ROS in M. tuberculosis (Figure 3.11 and Figure 3.12).  According to Dwyer et al. (2009), 
some antibiotics induce the formation of ROS in their bactericidal activity. We observed that CFZ and 
INH result in the production of ROS in a time dependant manner (Figure 3.13). This has been observed 
previously by staining with hydroxyphenyl fluorescein after INH treatment of M. tuberculosis and DHE 
after CFZ treatment (Kim et al., 2012;Goletti et al., 2013;Yano et al., 2011;Lamprecht et al., 2016). 
However, RIF treatment did not produce ROS as shown by Piccaro et al. (2014) who used electron 
paramagnetic resonance spin trapping to identify hydroxyl radical formation by RIF. Based on our 
results, the fluoroquinolones and STR did not seem to produce ROS (Figure 3.13).  When we evaluated 




CellROX negative subpopulation was slightly enriched for survival. This suggests that at early time 
points in CFZ treatment the staining patterns could be used to predict viability using CellROX Deep 
red. Unfortunately, this does not apply for RIF at early and later time points. Further work is ongoing 
to determine if CellROX can detect survival at lower drug concentrations.  
Our main challenge has been identifying a stain which predicts viability. This could have been due to 
the fact that we used the plating method to verify viability. Unfortunately this is the only method we 
could use because the CFU plating method remains the gold standard for measuring viability, and so 
we cannot rule out the presence of viable but not culturable cells. Repeating the experiments using 
liquid media to recover persistors could result in us recovering a greater proportion of this poorly 
culturable subpopulation.  It will be interesting to compare the transcription and proteomic profiles of 
different subpopulations to identify what drives differences in staining. Our antibiotic treatment was 
done using cells in early log phase and lasted for at least 72 hours because we wanted to identify a 
biomarker which could work both in the early stages of growth and later stages of growth. 
Unlike other researchers who use heat killed controls, our gates were based on the unstained control 
and stained pre-treatment control as we were interested in evaluating changes in staining induced by 
antibiotics. We evaluated single stains for viability because before we could evaluate dually stained 
populations it was important to know the if single staining could predict viability after treatment with 
any of the antibiotics. It would be interesting to further evaluate the dually stained subpopulations from 
RIF and CFZ treated cells as well as from other antibiotics. Ultimately, we would like to test our 
techniques on bacteria that have been sorted directly from sputum samples, especially as staining of 
sputum with FDA has been associated with monitoring treatment outcome (Schramm et al., 
2012;Kanade et al., 2016).   
We treated for only 72 hours in the majority of our experiments and it could be argued that true 
persisters, especially in the case of slow growing organisms, only emerge after longer periods of 
treatment. To some extent this is supported by an increase in PI staining after one week and at later 
timepoints in the work of others (Hendon-Dunn et al., 2016). However at the concentrations of drug 
used we found at least a 10-fold reduction in culturable bacteria (Appendix F). So what is the state of 
the 90% of bacteria that are not culturable? Are they truly dead, or dying or in a potentially resuscitable 
state given the right conditions? It is our belief that the majority of them are in fact dead and it is for 
this reason we selected early timepoints based on the kill kinetics of some of these antibiotics (Keren et 
al., 2011),  in order to maximise the chances of finding survivors. However from the results we observed 
here it may be advantegeous to treat for a longer time, at least 168 hours or even longer.  For treatment 
longer than 168 hours there will be a need to add more antibiotic depending on the stability and adopt 
strategies to flow many millions of bacteria to detect the anticipated  <1% of culturable organisms 




the tolerant phenotype is subtle and is only apparent at concentrations lower than the 10X MIC we used. 
However lower concentrations may not be relevant clinically and run the risk of selecting for resistance.  
Müller and Nebe-von-Caron (2010) stated that the suitability of fluorescent dyes and staining protocols 
can only be understood by optimising for each bacterial species. Here we showed the challenges of 
using FACS in monitoring survival during antibiotic treatment in M. tuberculosis. We observed that the 
fluorescent dyes cannot be applied to all antibiotics and the interpretation of the staining patterns is not 
universal. This suggests that for M. tuberculosis, the dye to be used depends on the antibiotic and the 
mechanism of action. The application of fluorescent dyes to M. tuberculosis may be also be problematic 
due to the nature of the cell wall which acts as a barrier to antibiotics and dyes (Sarathy et al., 
2013;Rodrigues et al., 2015) . If FACS is to be used to monitor survival during antibiotic treatment a 
newer generation of stains may need to be developed. Reporter strains which express fluorescent 
proteins can also be used to monitor the expression of specific metabolic pathways or stress response 
proteins such as IniBAC response in cells exposed to antibiotic treatment (Tan and Russell, 2015;Boot 
et al., 2016;Liu et al., 2016). These would overcome the membrane barrier which effects the uptake of 
fluorescent dyes.  
In conclusion we observed drug specific staining patterns with marked heterogeneity for most of the 
stains and antibiotics tested. Amongst the stains evaluated we found that after 24 hours of  CFZ 
treatment, CellROX Deep red negative cells were enriched for viable bacteria. Further work is now 
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Preparation of media 
Middlebrook 7H9 media 
 Middlebrook 7H9 broth base (Becton Dickinson) 4.9 g per litre. 
 Powder dissolved in 900 mL deionised water. 
 10mL of 50% glycerol, 2.5 mL of 80% Tween and 100 mL oleic -albumin- dextrose -catalase 
(OADC) enrichment (Becton Dickinson) added. 
 Media filter sterilised (Sigma 1 L filter systems) and stored at 4 ºC 
Middlebrook 7H10 Agar plates 
 Middlebrook 7H10 agar base (Becton Dickinson) 19 g per litre. Dissolved in 9000 mL 
deionised water. 
 10 mL of 50% glycerol added. 
 Agar autoclaved at 121 ºC for 15 minutes. 
 Allowed to cool to 65 °C then 100 mL OADC enrichment added  
 Poured 25 mL into petri dish and allowed to set  






Preparation of Antimicrobial stock solutions 
 Antimicrobial powder (Sigma Aldrich) was dissolved in respective solvent to make 10 mg/mL 
stock solution immediately before use.  
 This was the working concentration for most antibiotics except INH, EMB and CFZ. 
 The working concentration for INH, EMB and CFZ was 1 mg/mL. 
Solvents used to dissolve antibiotics and concentrations of antibiotic used. 
Antibiotic Solvent MIC concentration 
(µg/mL) 
10X MIC concentration 
(µg/mL) 
INH Sterile deionised water 0.1 1 
RIF Dimethyl sulfoxide  0.4 4 
EMB Sterile deionised water 0.1 1 
Fluoroquinolones (OFX, 
LVX, MOX) 
0.1M NaOH 1 – LVX and OFX 
0.5 - MOX 
10 – LVX and OFX 
5 - MOX 
STR Sterile deionised water 0.1 1 








Properties of the fluorescent dyes and cytometer settings 
Fluorescent dye / Parameter Filter PMT voltage 
Calcein blue DAPI 425 
Calcein green FITC 450 
FDA FITC 450 
PI PI 550 
Sytox red Alexa Fluor 647 522 
DiOC2 (3) – green fluorescence Alexa Fluor 488 444 
DiOC2 (3) – red fluorescence PerCP-Cy5.5 511 
DiBAC4 (3) FITC 450 
CellROX Green FITC 450 
CellROX Deep red APC 400 
CellROX Orange PE 438 
DHE PerCP-Cy5.5 511 
FSC FSC 100 





















Final concentrations of fluorescent dyes 
Fluorescent dye  Final concentration 
Calcein blue 5 µg/mL 
Calcein green 5 µg/mL 
FDA 2.5 µg/mL 
PI 2 µg/mL 
Sytox red 5 µg/mL 
DiOC2 (3)  15 µM 
DiBAC4 (3) 0.05 µg/mL 
CellROX Green 5 µM 
CellROX Deep red 5 µM 










Figure A1. Evaluating ROS production by anti-TB drugs using CellROX deep red. Cells were stained in 
triplicate with CellROX Deep red to measure ROS production after 24 and 72 hours of drug treatment. The 
histograms show that there were very subtle changes in the fluorescence intensity after treatment with 
fluoroquinolones (LVX, MOXI and OFX). There was a great increase in the CellROX Deep red fluorescence 
intensity after CFZ and INH treatment. There were minimal changes in the fluorescence intensity after STR and 
RIF treatment. The y axis shows the median fluorescence intensity. The x axis shows the different antibiotic 

























Figure A2. Killing kinetics during treatment with different antibiotics. Cells were stained in triplicate with 
different fluorescent stains after antibiotic treatment. A specific number of events was sorted from different 
subpopulations and plated for CFU. The observed CFU was used to calculate the CFU/ml. I – PI staining, II – 
sytox red, III – calcein blue and IV – CellROX deep red. There was approximately 90% killing after 72 hours of 
OFX and more than 90% killing after RIF and INH treatment. CFZ treatment however showed about 50% killing 
after 72 hours. There were very minimal differences between the negative and positive subpopulations from the 
different subpopulations. Error bars represent standard deviation. 
